SMTL ID : 5lz7.1

Fragment-based inhibitors of Lipoprotein associated Phospholipase A2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: Y.279, P.280, A.281 Ligand excluded by PLIP

1 x 7BK: 2-fluoranyl-5-[2-[(4~{R})-4-methyl-2-oxidanylidene-4-phenyl-pyrrolidin-1-yl]ethoxy]benzenecarbonitrile(Non-covalent)

7BK.2: 18 residues within 4Å: Chain A: L.62, F.65, G.107, L.108, G.109, A.110, L.114, Y.115, H.227, S.228, F.229, W.253, F.277, H.306, Q.307, A.310, D.311, F.312 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.65, A:L.108, A:L.108, A:W.253, A:W.253, A:F.277, A:A.310 Hydrogen bonds: A:L.108, A:F.229, A:Q.307, A:D.311, A:F.312 Water bridges: A:T.313 pi-Stacking: A:W.253

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Woolford, A.J. et al., Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2). J. Med. Chem. (2016)

Release Date

2016-12-21

Peptides

Platelet-activating factor acetylhydrolase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Platelet-activating factor acetylhydrolase

Related Entries With Identical Sequence